Skip to main content
Fig. 3 | Cardiovascular Diabetology

Fig. 3

From: Efficacy and safety of enavogliflozin vs. dapagliflozin as add-on therapy in patients with type 2 diabetes mellitus based on renal function: a pooled analysis of two randomized controlled trials

Fig. 3

The relationship between eGFR and the change in urine glucose-to-creatinine ratio from baseline. The horizontal line shows the continuous UGCR change from baseline across the range of eGFR and the shaded area around this line represents the 95% CI obtained via Pearson’s correlation analysis

Back to article page

Cardiovascular Diabetology

ISSN: 1475-2840